AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 180 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,437,000 | -25.9% | 40,782 | -39.7% | 0.44% | -0.2% |
| Q3 2017 | $3,289,000 | -14.2% | 67,668 | -7.2% | 0.44% | -31.0% |
| Q2 2017 | $3,832,000 | -9.1% | 72,930 | -21.5% | 0.63% | -4.7% |
| Q1 2017 | $4,216,000 | +10.5% | 92,963 | -7.7% | 0.66% | +31.0% |
| Q4 2016 | $3,814,000 | -19.1% | 100,759 | -19.3% | 0.51% | -19.9% |
| Q3 2016 | $4,715,000 | +30.8% | 124,932 | +8.6% | 0.63% | +52.2% |
| Q1 2015 | $3,605,000 | -4.9% | 115,038 | -11.4% | 0.42% | -21.4% |
| Q4 2014 | $3,789,000 | +98.0% | 129,816 | +40.4% | 0.53% | +36.0% |
| Q3 2014 | $1,914,000 | +160.1% | 92,489 | +211.1% | 0.39% | +177.9% |
| Q2 2014 | $736,000 | – | 29,730 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |